Press
We are launching Wepredic!
Wepredic gathers four key players in in vitro technologies for toxicology and pharmacokinetics.
Christophe Chesné, Ph.D, CEO of Eurosafe, is also the founder of Biopredic International, Starlight and Advancells. With their long-standing expertise in in vitro technologies for toxicology and pharmacokinetics, these companies support the world's leading pharmaceutical, cosmetic and chemical companies every day.
Wepredic has been founded to unite these four brands and deliver in vitro testing solutions that aim to replace laboratory animals.
Discover Christophe Chesné's editorial on the reasons for this strategic move.